| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |